These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9859073)

  • 21. MATCH results: implications for the internist.
    Lutsep HL
    Am J Med; 2006 Jun; 119(6):526.e1-7. PubMed ID: 16750967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiplatelet therapy in the treatment of cerebrovascular disease.
    Couch JR
    Clin Cardiol; 1993 Oct; 16(10):703-10. PubMed ID: 8222382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary stroke prevention set to benefit from PRoFESS trial: extended-release dipyridamole plus aspirin (Asasantin Retard) and clopidogrel share very similar benefit-risk ratio in vascular prevention.
    Cardiovasc J Afr; 2008; 19(3):165. PubMed ID: 18568182
    [No Abstract]   [Full Text] [Related]  

  • 24. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antiplatelet drugs for prevention of cerebral ischemic accidents].
    Crassard I; Bousser MG
    Rev Neurol (Paris); 1999 Sep; 155(8):531-41. PubMed ID: 10486843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antithrombotic drugs for the secondary prevention of ischemic stroke.
    Nenci GG; Goracci S
    Ann Ital Med Int; 2000; 15(4):282-90. PubMed ID: 11202630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary prevention of ischaemic stroke and TIA.
    Diener HC
    Cardiovasc J Afr; 2008; 19(4):229. PubMed ID: 18776974
    [No Abstract]   [Full Text] [Related]  

  • 28. Aspirin and dipyridamole for the secondary prevention of stroke.
    Zielinski R; French L
    J Fam Pract; 1999 Feb; 48(2):92. PubMed ID: 10037534
    [No Abstract]   [Full Text] [Related]  

  • 29. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
    Gebel JM
    J Am Coll Cardiol; 2005 Sep; 46(5):752-5. PubMed ID: 16139120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiplatelet drugs for ischemic stroke prevention.
    Leys D; Balucani C; Cordonnier C
    Cerebrovasc Dis; 2009; 27 Suppl 1():120-5. PubMed ID: 19342841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
    Bhatt DL; Topol EJ;
    Am Heart J; 2004 Aug; 148(2):263-8. PubMed ID: 15308995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ticlopidine: a new antiplatelet agent for the secondary prevention of stroke.
    Murray JC; Kelly MA; Gorelick PB
    Clin Neuropharmacol; 1994 Feb; 17(1):23-31. PubMed ID: 8149356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of ticlopidine and aspirin for the prevention of stroke.
    N Engl J Med; 1990 Feb; 322(6):404-5. PubMed ID: 2300095
    [No Abstract]   [Full Text] [Related]  

  • 34. Antiplatelet agents for prevention of recurrent ischemic stroke.
    Hegge KA
    S D Med; 2009 Jan; 62(1):15-7. PubMed ID: 19245087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiplatelet agents and randomized trials.
    Diener HC
    Rev Neurol Dis; 2007; 4(4):177-83. PubMed ID: 18195669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secondary prevention of stroke--new trials.
    Forbes CD
    Scott Med J; 1998 Feb; 43(1):5-6. PubMed ID: 9533250
    [No Abstract]   [Full Text] [Related]  

  • 37. [Secondary stroke prevention according to the PRoFESS Study. What are the sequelae for practical therapy?].
    Diener C
    MMW Fortschr Med; 2008 May; 150(21):7. PubMed ID: 18578065
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prevention of thrombosis after ischemic cerebrovascular attack--new possibilities].
    Boysen G
    Ugeskr Laeger; 1998 Jul; 160(30):4432-3. PubMed ID: 9691838
    [No Abstract]   [Full Text] [Related]  

  • 39. Current use of antiplatelet drugs in stroke syndromes in the USA.
    Nelson E
    Ann N Y Acad Sci; 1990; 598():368-75. PubMed ID: 2248449
    [No Abstract]   [Full Text] [Related]  

  • 40. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
    Diener HC
    Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.